MenB Vaccination in the UK: Understanding the Coverage Gap

Primary Cause and Routine Introduction

MenB is identified as the primary cause of meningococcal meningitis within the United Kingdom. This serious bacterial infection can lead to life-threatening complications.

Routine vaccination against MenB was introduced in the UK in 2015. This public health measure aimed to protect populations from the severe disease.

Consequently, individuals currently in their late teens and the student population who were born before this rollout are not covered by the routine vaccination program.

This highlights a significant demographic that did not receive the vaccine as part of their standard childhood immunization schedule.